View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Modality Solutions
14 March 2017

Modality Solutions’ Daniel Littlefield Leads Roundtable Discussion at 17th Annual World Vaccine Congress (WVA), Washington

Modality Solutions has announced its sponsorship and roundtable leadership at the 17th Annual World Vaccine Congress (WVA) in Washington, DC.

Taking place from 10 April 10 to12 April at the Grand Hyatt, the congress promotes research, development, and strategic partnering for the global vaccine industry.

Principal at Modality Solutions Daniel Littlefield will lead an interactive roundtable discussion on the first day at 11:20. Titled ‘Managing Your Cold Chain – Lessons Learned from the Ebola Clinical Trials’, Littlefield will cover the topic, ‘Are you effectively managing temperature requirements in your clinical trials in Zone 4 climate zones?’.

The discussion will include management of multiple temperature ranges from <-60°C to 8°C, transport and storage with minimal infrastructure to remote depots and clinical trial sites, and compliance by partnering with the local regulatory authorities.

Daniel said: "I invite Congress attendees to join my interactive roundtable.

"Come and learn practical solutions for the real-world challenges that led to a flawless execution of the STRIVE Ebola clinical trial in sub-Saharan Africa with zero temperature excursions."

Modality Solutions’ president Gary Hutchinson said: "Our sponsorship and participation in the WVA supports our continued commitment to work with vaccine experts from top pharmaceutical and biotechnology companies worldwide.

"The congress will cover some of the crucial technological developments that are changing how vaccines are researched, manufactured, and distributed."

WVA Washington is well-established as one of the leading events on vaccines each year. Now in its seventeenth year, attendees are guaranteed one of the best experiences on-site.

The congress will cover crucial topics affecting the whole sector. Leadership anticipates more than 700 senior vaccine executives will take advantage of the event and eight co-located streams on immune profiling, cancer and immunotherapy, influenza and respiratory, clinical trials, emerging diseases, partnerships, veterinary vaccines, and bioprocessing and manufacturing.

Competing priorities, changing expectations, cost pressures, sustainability initiatives, emerging markets - these are some of the challenges facing cold chain management professionals every day. Solutions...
Regenerative medicine is a novel biomolecular approach to exciting new clinical therapies. Generally, this grouping involves three major therapy applications: cell therapies or stem cell...
Immunomedics ( is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer.
Bristol-Myers Squibb (BMS) is a global biopharmaceutical company headquartered in New York City that specialises in discovering, developing and delivering innovative medicines for patients with...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology